Neonatal Abstinence Syndrome

Basics

Basics

Basics

Description

Description

Description

  • Neonatal abstinence syndrome (NAS) occurs due to intrauterine exposure to maternal opioid medications (whether the mother is on maintenance opioid therapy, using illicit opioids, or abusing licit opioids), causing a postnatal withdrawal syndrome.
  • Signs of NAS include gastrointestinal (GI) tract dysfunction, central nervous system (CNS) irritability, and autonomic overreactivity following birth secondary to a lack of maternal drug supply.
  • Iatrogenic drug withdrawal syndrome may be seen in infants and children treated with opioids (following severe illness or surgery with similar symptoms) but is not the focus of this chapter.

Epidemiology

Epidemiology

Epidemiology

Incidence

Incidence

Incidence

  • NAS symptoms occur in 55–94% of neonates with intrauterine opioid exposure.
  • Marked rise from 1.5 cases per 1,000 live births in 1999 to 6 cases per 1,000 live births in 2013

Risk Factors

Risk Factors

Risk Factors

Maternal: Chronic pain, medication-seeking behaviors, opioid maintenance therapy, report of drug abuse, multidrug use (e.g., nicotine, benzodiazepines, trazodone, SSRIs), homelessness, history of sexual abuse, or domestic violence

  • 4.5% of pregnant women age 15 to 44 years reported recent use of illicit drugs.
  • 6% of mothers reported use of prescription opioids for >1 month of pregnancy.

General Prevention

General Prevention

General Prevention

  • Prenatal education and counseling of at-risk women
  • Prenatal treatment—opioid maintenance therapy
  • Prevention of abrupt drug cessation during pregnancy

Pathophysiology

Pathophysiology

Pathophysiology

  • Opiates are low-molecular-weight, water soluble, lipophilic compounds that easily cross placenta, increasingly as gestation progresses.
  • Opioids easily cross fetal blood–brain barrier.
  • Opioid receptors are extensive in CNS as well as the peripheral nervous system, GI tract, and other organ systems.
  • Opioids have a prolonged half-life in fetus.
  • Neonatal neurobehavioral dysregulation is the major manifestation of NAS.

Etiology

Etiology

Etiology

Intrauterine exposure to maternal licit or illicit opioid use, with cessation of the exposure at clamping and cutting of the umbilical cord

Commonly Associated Conditions

Commonly Associated Conditions

Commonly Associated Conditions

  • Premature birth
  • Placental abruption
  • Poor intrauterine growth and/or small for gestational age
  • Feeding problems
  • Seizures (uncommon)
  • Birth defects (rare)

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.